(BPT) – For years  doctors treated lung cancer as one disease The discovery of molecular biomarkers and advent of biomarker-driven therapies  however  has led to the understanding that lung cancer is actually made up of many distinct subtypes  which impacts the way the disease is diagnosed and treated